Pattern of Retinopathy: Although the locus of toxic damage is parafoveal in many eyes, Asian patients often show an extramacular pattern of damage. Dose: We recommend a maximum daily HCQ use of 5.0 mg/kg real weight, which correlates better with risk than ideal weight. Plaquenil for seronegative arthritis Plaquenil eyes hurt Chloroquine aralen dosage Plaquenil hydroxychloroquine sulfate, Sanofi-Aventis and the less-used chloroquine are antimalarial drugs with anti-inflammatory properties that are used for the management of a spectrum of inflammatory conditions. Provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Besides Plaquenil and Chloroquine, what other drug is known to cause Bull's eye Maculopathy? HVF 24-2 or 30-2 instead of 10-2 because damage tends to be further from the fovea Do SD-OCT scans outside of fovea too- FAF is a good choice Risk of Toxicity: The risk of toxicity is dependent on daily dose and duration of use. There are no similar demographic data for CQ, but dose comparisons in older literature suggest using 2.3 mg/kg real weight. Management of plaquenil maculopathy Maculopathy - an overview ScienceDirect Topics, Hydroxychloroquine Professional Patient Advice - Hydroxychloroquine sulphate brand nameEye side effects of plaquenilAtp quantification assay chloroquineDress hydroxychloroquine Plaquenil hydroxychloroquine sulfate tablets contain 200 mg hydroxychloroquine sulfate, equivalent to 155 mg base, and are for oral administration. Plaquenil - FDA prescribing information, side effects and uses. Ocular Side effects of Oral Medications Flashcards Quizlet. Eye screening for patients taking hydroxychloroquine Plaquenil. Find user ratings and reviews for Plaquenil oral on WebMD including side effects and drug interactions, medication effectiveness, ease of use and satisfaction Hydroxychloroquine HCQ; Plaquenil is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncology. These medications are initially used in the prophylaxis and treatment of malaria. Plaquenil has replaced chloroquine because it produces less retinal side effects. Aside from its initial intended use, it has been also used for the management of rheumatoid arthritis, systemic lupus erythematosus and several other connective tissue disorders 1.